Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
Phytotherapy Research : PTR|January 18, 2017
A systematic review on ethnomedicines of anti-cancer plantsAkash Tariq, Sehrish Sadia, Kaiwen Pan, et al.
Plos One|June 29, 2022
Curcumin improves D-galactose and normal-aging associated memory impairment in mice: In vivo and in silico-based studiesMd Ashrafur Rahman, Arif Anzum Shuvo, Asim Kumar Bepari, et al.
Frontiers in Psychiatry|October 31, 2022
Thwarted belongingness, perceived burdensomeness, and acquired capability for suicide among university students of Bangladesh: Scales validation and status assessmentS M Yasir Arafat, Fahad Hussain, Mir Susmita Zaman, et al.
Health Science Reports|July 21, 2025
Technology Addiction: Effects of Electronic Games and Social Media Use on Academic Performance and Symptoms of Psychiatric Disorders Among School-Age AdolescentsMosiur Rahman, Prosannajid Sarkar, Syed Emdadul Haque, et al.
Global Heart|December 9, 2024
Decomposing the Poor-Non-Poor Gap in the Prevalence of Undiagnosed and Untreated Hypertension Among Bangladeshi PopulationMosiur Rahman, Mahfuza Khatun, Asrafun Naher Pinkey, et al.
The Lancet. Haematology|July 30, 2021
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trialTapan M Kadia, Patrick K Reville, Gautam Borthakur, et al.
Journal of Infection and Public Health|November 29, 2022
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategiesKuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
The Lancet. Haematology|March 7, 2024
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 studyAlexandre Bazinet, Guillermo Garcia-Manero, Nicholas Short, et al.
American Journal of Hematology|August 28, 2023
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemiaTapan M Kadia, Farhad Ravandi, Matteo Molica, et al.
JAMA Neurology|May 23, 2025
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021, Ilari Rautalin, Victor Volovici, et al.
Pageof 31